Difference between revisions of "UMODL1-AS1"
| (4 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
==Annotated Information== | ==Annotated Information== | ||
| + | [[File:LncRNA signature for recurrence based on RNA expression.jpg|right|thumb|400px|'''LncRNA signature for recurrence based on RNA expression'''<ref name="ref1" />]] | ||
| + | [[File:Alterations of lncRNAs associated with ER, PR and HER-2.png|right|thumb|480px|'''Alterations of lncRNAs associated with ER, PR and HER-2'''<ref name="ref1" />]] | ||
===Approved Symbol=== | ===Approved Symbol=== | ||
| − | UMODL1-AS1 | + | UMODL1-AS1 （UMODL1 antisense RNA 1） |
| − | |||
| − | |||
===Previous Symbols=== | ===Previous Symbols=== | ||
C21orf128 | C21orf128 | ||
| Line 16: | Line 16: | ||
===Ensembl ID=== | ===Ensembl ID=== | ||
ENSG00000184385 | ENSG00000184385 | ||
| − | === | + | ===Function=== |
| − | + | UMODL1-AS1's upregulation can predict recurrence of breast cancer.<ref name="ref1" /> UMODL1-AS1 is significantly associated with ER and triple negative status.<ref name="ref1" /> | |
| − | === | + | ==Labs working on this lncRNA== |
| − | > | + | * Cancer Institute, University of Mississippi Medical Center, Jackson, MS, USA. <ref name="ref1" /> |
| − | < | + | ==References== |
| + | <references> | ||
| + | <ref name="ref1"> 1: Liu H, Li J, Koirala P, Ding X, Chen B, Wang Y, Wang Z, Wang C, Zhang X, Mo YY. Long non-coding RNAs as prognostic markers in human breast cancer.Oncotarget. 2016 Apr 12;7(15):20584-96. doi: 10.18632/oncotarget.7828. | ||
| + | </ref>(1) | ||
| + | </references> | ||
Latest revision as of 13:14, 7 January 2018
Contents
Annotated Information
LncRNA signature for recurrence based on RNA expression[1]
Alterations of lncRNAs associated with ER, PR and HER-2[1]
Approved Symbol
UMODL1-AS1 （UMODL1 antisense RNA 1）
Previous Symbols
C21orf128
Synonyms
FLJ33471
Chromosome
21q22.3
RefSeq ID
NR_027243
Disease
breast cancer
Ensembl ID
ENSG00000184385
Function
UMODL1-AS1's upregulation can predict recurrence of breast cancer.[1] UMODL1-AS1 is significantly associated with ER and triple negative status.[1]
Labs working on this lncRNA
- Cancer Institute, University of Mississippi Medical Center, Jackson, MS, USA. [1]
